Author:
Hočevar Alojzija,Kopač Peter,Rotar Žiga,Novljan Martina Plešivčnik,Škrgat Sabina
Reference6 articles.
1. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides;Jennette;Arthritis Rheum,2013
2. Eosinophils in vasculitis: characteristics and roles in pathogenesis;Khoury;Nat Rev Rheumatol,2014
3. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis;Wechsler;N Engl J Med,2017
4. Two-year integrated efficacy and safety analysis of benralizumab in severe asthma;FitzGerald;J Asthma Allergy,2019
5. A study to evaluate if benralizumab compared to mepolizumab may be beneficial in the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (MANDARA). ClinicalTrials.gov identifier: NCT04157348. Updated March 25, 2020. Available from: https://clinicaltrials.gov/ct2/show/NCT04157348. Accessed May 5, 2020.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献